Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.

MLA

Yang, Tao-Chieh, et al. “Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.” International Journal of Molecular Sciences, vol. 22, no. 11, June 2021, p. 5557. EBSCOhost, https://doi.org/10.3390/ijms22115557.

APA

Yang, T.-C., Liu, S.-J., Lo, W.-L., Chen, S.-M., Tang, Y.-L., & Tseng, Y.-Y. (2021). Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle. International Journal of Molecular Sciences, 22(11), 5557. https://doi.org/10.3390/ijms22115557

Chicago

Yang, Tao-Chieh, Shih-Jung Liu, Wei-Lun Lo, Shu-Mei Chen, Ya-Ling Tang, and Yuan-Yun Tseng. 2021. “Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.” International Journal of Molecular Sciences 22 (11): 5557. doi:10.3390/ijms22115557.